PLK2 and Insulin resistance: Insulin resistance and T2DM lead to low Parkin and PGC1α levels, which impair mitochondrial proteins and genome expression, downregulate polo-like kinase-2(PLK2), increase ROS production, and cause abnormal mitochondrial metabolism [95].